The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
From antimicrobial to anticancer peptides. A review
Open accessAbstract
Antimicrobial peptides (AMPs) are part of the innate immune defense mechanism of many organisms. Although AMPs have been essentially studied and developed as potential alternatives for fighting infectious diseases, their use as anticancer peptides (ACPs) in cancer therapy either alone or in combination with other conventional drugs has been regarded as a therapeutic strategy to explore. As human cancer remains a cause of high morbidity and mortality worldwide, an urgent need of new, selective, and more efficient drugs is evident. Even though ACPs are expected to be selective toward tumor cells without impairing the normal body physiological functions, the development of a selective ACP has been a challenge. It is not yet possible to predict antitumor activity based on ACPs structures. ACPs are unique molecules when compared to the actual chemotherapeutic arsenal available for cancer treatment and display a variety of modes of action which in some types of cancer seem to co-exist. Regardless the debate surrounding the definition of structure-activity relationships for ACPs, great effort has been invested in ACP design and the challenge of improving effective killing of tumor cells remains. As detailed studies on ACPs mechanisms of action are crucial for optimizing drug development, in this review we provide an overview of the literature concerning peptides' structure, modes of action, selectivity, and efficacy and also summarize some of the many ACPs studied and/or developed for targeting different solid and hematologic malignancies with special emphasis on the first group. Strategies described for drug development and for increasing peptide selectivity toward specific cells while reducing toxicity are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“In these tumors it is possible to distinguish malignant cells and the stroma where these cells are maintained (Dvorak et al., 1986).”
BackgroundAntimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
Arap, W., Pasqualini, R., & Ruoslahti, E. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,054
The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.
Brown, J. M., & Giaccia, A. J. (1998) · PubMed · Cited by 1,748
EGFR exon 20 insertion A763-Y764insFQEA and response to erlotinib-letter
Xu, S., Garofalo, A., Neamati, N., & GRANDE, F. (2011) · National University of Singapore · doi:10.1158/1535-7163 · Cited by 1,690
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
Dube, D. H., & Bertozzi, C. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1751 · Cited by 1,598
Studies on anticancer activities of antimicrobial peptides
Hoskin, D. W., & Ramamoorthy, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.008 · Cited by 1,296
Malard, F., Wolter, A. C., Marquevielle, J., Morvan, E., Ecoutin, A., Rüdisser, S. H., Allain, F. H. T., & Campagne, S. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae201 · Cited by 1,273
The role of cationic antimicrobial peptides in innate host defences
Hancock, R. E. W., & Diamond, G. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01823-0 · Cited by 1,218
Antimicrobial peptides: premises and promises
Reddy, K. V. R., Yedery, R. D., & Aranha, C. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.09.005 · Cited by 1,068
Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action
Chan, D. I., Prenner, E. J., & Vogel, H. J. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.04.006 · Cited by 1,039
APD2: the updated antimicrobial peptide database and its application in peptide design.
Wang, G., Li, X., & Wang, Z. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn823 · Cited by 941
Self-renewal and solid tumor stem cells
Al-Hajj, M., & Clarke, M. F. (2004) · Oncogene · doi:10.1038/sj.onc.1207947 · Cited by 914
Mode of action of linear amphipathic α-helical antimicrobial peptides
Oren, Z., & Shai, Y. (1998) · Biopolymers · doi:10.1002/(sici)1097-0282(1998)47:6<451::aid-bip4>3.0.co;2-f · Cited by 848
Role of lipids in the interaction of antimicrobial peptides with membranes
Teixeira, V., Feio, M. J., & Bastos, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.12.005 · Cited by 692
Antimicrobial peptides: an overview of a promising class of therapeutics
Giuliani, A., Pirri, G., & Nicoletto, S. (2007) · Open Life Sciences · doi:10.2478/s11535-007-0010-5 · Cited by 606
Utsugi, T., Schroit, A. J., Connor, J., Bucana, C. D., & Fidler, I. J. (1991) · PubMed · Cited by 594
Detergent-like actions of linear amphipathic cationic antimicrobial peptides
Bechinger, B., & Lohner, K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.07.001 · Cited by 593
A reconfigurable analog VLSI neural network architecture with non linear synapses
M., B. G., Stratta, R., Trucco, E., CAVIGLIA, D., & VALLE, M. (1998) · CINECA IRIS Institutial Research Information System (University of Genoa) · doi:10.1002/(sici)1097 · Cited by 576
Li, Y. C., Park, M. J., Ye, S.-K., Kim, C.-W., & Kim, Y.-N. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050959 · Cited by 536
Cationic amphiphilic peptides with cancer-selective toxicity
Schweizer, F. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.043 · Cited by 517
Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug Treatment
Perez-Tomas, R. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706777585077 · Cited by 509
Host defense peptides as new weapons in cancer treatment
Papo, N., & Shai, Y. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4560-2 · Cited by 501
Antimicrobial Peptides for Therapeutic Applications: A Review
Seo, M.-D., Won, H.-S., Kim, J.-H., Mishig-Ochir, T., & Lee, B.-J. (2012) · Molecules · doi:10.3390/molecules171012276 · Cited by 492
Antibacterial Action of Structurally Diverse Cationic Peptides on Gram-Positive Bacteria
Friedrich, C. L., Moyles, D., Beveridge, T. J., & Hancock, R. E. W. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2086-2092.2000 · Cited by 464
Li, Y., Xiang, Q., Zhang, Q., Huang, Y., & Su, Z. (2012) · Peptides · doi:10.1016/j.peptides.2012.07.001 · Cited by 462
Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion.
Davies, B. P., Waxman, J., Wasan, H. S., Abel, P., Williams, G., Krausz, T. N., Neal, D. E., Thomas, D., Hanby, A. M., & Balkwill, F. R. (1993) · PubMed · Cited by 430
Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment
Mader, J. S., & Hoskin, D. W. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.8.933 · Cited by 430
Riedl, S., Zweytick, D., & Lohner, K. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.09.004 · Cited by 405
Nylandsted, J., Rohde, M., Brand, K., Bastholm, L., Elling, F., & Jäättelä, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.7871 · Cited by 393
A Re-evaluation of the Role of Host Defence Peptides in Mammalian Immunity
Bowdish, D., Davidson, D., & Hancock, R. (2005) · Current Protein & Peptide Science · doi:10.2174/1389203053027494 · Cited by 368
Cruciani, R. A., Barker, J. L., Zasloff, M., Chen, H. C., & Colamonici, O. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3792 · Cited by 362
Riedl, S., Rinner, B., Asslaber, M., Schaider, H., Walzer, S., Novak, A., Lohner, K., & Zweytick, D. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.07.026 · Cited by 331
Cociancich, S., Ghazi, A., Hetru, C., Hoffmann, J. A., & Letellier, L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36505-6 · Cited by 319
Natural roles of antimicrobial peptides in microbes, plants and animals
Maróti, G., Kereszt, A., Kondorosi, É., & Mergaert, P. (2011) · Research in Microbiology · doi:10.1016/j.resmic.2011.02.005 · Cited by 298
Binding and action of cecropin and cecropin analogues: Antibacterial peptides from insects
Steiner, H., Andreu, D., & Merrifield, R. B. (1988) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(88)90069-7 · Cited by 298
Doxorubicin-induced apoptosis: Implications in cardiotoxicity
Kalyanaraman, B., Joseph, J., Kalivendi, S., Wang, S., Konorev, E., & Kotamraju, S. (2002) · Oxygen/Nitrogen Radicals: Cell Injury and Disease · doi:10.1007/978-1-4615-1087-1_13 · Cited by 296
Doxorubicin-induced apoptosis: Implications in cardiotoxicity
Kalyanaraman, B., Joseph, J., Kalivendi, S., Wang, S., Konorev, E., & Kotamraju, S. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1015976430790 · Cited by 293
Changes in electric charge and phospholipids composition in human colorectal cancer cells
Dobrzyńska, I., Szachowicz-Petelska, B., Sulkowski, S., & Figaszewski, Z. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-3557-3 · Cited by 285
Bovine lactoferricin selectively induces apoptosis in human leukemia and carcinoma cell lines
Mader, J. S., Salsman, J., Conrad, D. M., & Hoskin, D. W. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0077 · Cited by 264
A proapoptotic peptide for the treatment of solid tumors.
Mai, J., Mi, Z., Kim, S.-H., Ng, B., & Robbins, P. D. (2001) · PubMed · Cited by 247
Alves, C. S., Melo, M. N., Franquelim, H. G., Ferre, R., Planas, M., Feliu, L., Bardají, E., Kowalczyk, W., Andreu, D., Santos, N. C., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.130955 · Cited by 233
Self-citationWachinger, M., Brack-Werner, R., Erfle, V, von Pechmann, N., Neumann, M., Winder, D., Kleinschmidt, A., Salmons, B., Ludvigsen, A., & Holle, R. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-4-731 · Cited by 227
Huang, Y.-B., Wang, X.-F., Wang, H.-Y., Liu, Y., & Chen, Y. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0811 · Cited by 224
D’Errico, A., Garbisa, S., Liotta, L. A., Castronovo, V., Stetler‐Stevenson, W. G., & Grigioni, W. F. (1991) · PubMed · Cited by 207
Fighting bacterial infections—Future treatment options
Fernebro, J. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.02.001 · Cited by 199
Yoo, Y., Watanabe, S., Watanabe, R., Hata, K., Shimazaki, K., & Azuma, I. (1997) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1997.tb00364.x · Cited by 197
Mechanism of anticancer activity of buforin IIb, a histone H2A-derived peptide
Lee, H. S., Park, C. B., Kim, J. M., Jang, S. A., Park, I. Y., Kim, M. S., Cho, J. H., & Kim, S. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.041 · Cited by 188
On the selectivity and efficacy of defense peptides with respect to cancer cells
Harris, F., Dennison, S. R., Singh, J., & Phoenix, D. A. (2013) · Medicinal Research Reviews · doi:10.1002/med.20252 · Cited by 185
Eliassen, L. T., Berge, G., Leknessund, A., Wikman, M., Lindin, I., Løkke, C., Ponthan, F., Johnsen, J. I., Sveinbjørnsson, B., Kogner, P., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21886 · Cited by 181
Overview of Tumor Cell Chemoresistance Mechanisms
Gatti, L., & Zunino, F. (2005) · Chemosensitivity · doi:10.1385/1-59259-889-7:127 · Cited by 179
A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers
LaBelle, J. L., Katz, S. G., Bird, G. H., Gavathiotis, E., Stewart, M. L., Lawrence, C., Fisher, J. K., Godes, M., Pitter, K., Kung, A. L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci46231 · Cited by 176
Anticancer β-Hairpin Peptides: Membrane-Induced Folding Triggers Activity
Sinthuvanich, C., Veiga, A. S., Gupta, K., Gaspar, D., Blumenthal, R., & Schneider, J. P. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210569f · Cited by 175
Self-citationWang, K.-R., Zhang, B.-Z., Zhang, W., Yan, J.-X., Li, J., & Wang, R. (2008) · Peptides · doi:10.1016/j.peptides.2008.01.015 · Cited by 174
Over‐expression of hsp70 confers tumorigenicity to mouse fibrosarcoma cells
Jäättelä, M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600520 · Cited by 170
Anti-Angiogenic Peptides for Cancer Therapeutics
V. Rosca, E., E. Koskimaki, J., G. Rivera, C., B. Pandey, N., P. Tamiz, A., & S. Popel, A. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111796117300 · Cited by 170
Papo, N., Shahar, M., Eisenbach, L., & Shai, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211204200 · Cited by 165
Preliminary experimental anticancer activity of cecropins.
Moore, A., Devine, D., & Bibby, M. C. (1994) · PubMed · Cited by 165
Membrane fluidity characteristics of human lung cancer
Sok, M., Šentjurc, M., & Schara, M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00044-0 · Cited by 163
Arouri, A., Dathe, M., & Blume, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.11.022 · Cited by 160
Peptides and Aptamers Targeting HSP70: A Novel Approach for Anticancer Chemotherapy
Rérole, A.-L., Gobbo, J., De Thonel, A., Schmitt, E., Pais de Barros, J. P., Hammann, A., Lanneau, D., Fourmaux, E., Deminov, O., Micheau, O., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1443 · Cited by 160
Hilchie, A. L., Doucette, C. D., Pinto, D. M., Patrzykat, A., Douglas, S. E., & Hoskin, D. W. (2011) · Breast Cancer Research · doi:10.1186/bcr3043 · Cited by 156
Human defensins as cancer biomarkers and antitumour molecules
Droin, N. M., Hendra, J.-B., Ducoroy, P., & Solary, É. (2009) · Journal of Proteomics · doi:10.1016/j.jprot.2009.01.002 · Cited by 156
Albrethsen, J., Bøgebo, R., Gammeltoft, S., Olsen, J., Winther, B. R., & Raskov, H. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-8 · Cited by 154
Doxorubicin-induced apoptosis: implications in cardiotoxicity.
Kalyanaraman, B., Joseph, J., Kalivendi, S., Wang, S., Konorev, E. A., & Kotamraju, S. (2002) · PubMed · Cited by 154
Targeting apoptosis as an approach for gastrointestinal cancer therapy
Qiao, L., & Yu, W. B. C. (2009) · Drug Resistance Updates · doi:10.1016/j.drup.2009.02.002 · Cited by 154
Recent Development in Carbohydrate-Based Cancer Vaccines
Guo, Z., & Wang, Q. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.08.010 · Cited by 149
Ren, S. X., Shen, J. S., Cheng, A. S. L., Lu, L., Chan, R. L. Y., Li, Z. J., Wang, X., Wong, C. C. M., Zhang, L., Ng, S. S. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063641 · Cited by 147
Papo, N., Seger, D., Makovitzki, A., Kalchenko, V., Eshhar, Z., Degani, H., & Shai, Y. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4569 · Cited by 139
Schröder-Borm, H., Bakalova, R., & Andrä, J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.084 · Cited by 133
Iwasaki, T., Ishibashi, J., Tanaka, H., Sato, M., Asaoka, A., Taylor, D., & Yamakawa, M. (2008) · Peptides · doi:10.1016/j.peptides.2008.12.019 · Cited by 133
Human α-Defensins HNPs-1, -2, and -3 in Renal Cell Carcinoma
Müller, C. A., Markovic‐Lipkovski, J., Klatt, T., Gamper, J., Schwarz, G., Beck, H., Deeg, M., Kalbacher, H., Widmann, S., Wessels, J. T., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62558-8 · Cited by 132
Designed Antimicrobial and Antitumor Peptides with High Selectivity
Hu, J. Y., Chen, C., Zhang, S., Zhao, X., Xu, H., Zhao, X., & Lu, J. R. (2011) · Biomacromolecules · doi:10.1021/bm201098j · Cited by 127
Chen, J., Lin, W.-J., & Lin, T.-L. (2009) · Peptides · doi:10.1016/j.peptides.2009.06.009 · Cited by 115
TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis
Yang, W., Luo, D., Wang, S., Wang, R., Chen, R., Liu, Y., Zhu, T., Ma, X., Liu, R., Xu, G., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0233 · Cited by 115
Antimicrobial Peptides: Multifunctional Drugs for Different Applications
Brandenburg, L., Merres, J., Albrecht, L.-J., Varoga, D. J., & Pufe, T. (2012) · Polymers · doi:10.3390/polym4010539 · Cited by 115
Yang, S., Shin, S. Y., Lee, C. W., Kim, Y., Hahm, K., & Kim, J. I. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00266-7 · Cited by 112
Wang, K., Yan, J., Zhang, B., Song, J., Jia, P.-F., & Wang, R. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.12.027 · Cited by 110
Johnstone, S. A., Gelmon, K. A., Mayer, L., Hancock, R. E. W., & Bally, M. B. (2000) · PubMed · Cited by 108
Rodrigues, E. G., Dobroff, A. S., Cavarsan, C. F., Paschoalin, T., Nimrichter, L., Mortara, R. A., dos Santos, E. L., Fázio, M. A., Miranda, A., Daffre, S., et al. (2008) · Neoplasia · doi:10.1593/neo.07885 · Cited by 104
Molecular mechanisms of antibacterial and antitumor actions of designed surfactant-like peptides
Chen, C., Hu, J., Shengzhong, Z., Zhou, P., Zhao, X., Xu, H., Zhao, X., Yaseen, M., & Lu, J. R. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.059 · Cited by 103
Kim, S., Kim, S. S., Bang, Y., Kim, S., & Lee, B. J. (2003) · Peptides · doi:10.1016/s0196-9781(03)00194-3 · Cited by 102
Jenssen, H., Andersen, J. H., Uhlin‐Hansen, L., Gutteberg, T. J., & Rekdal, Ø. (2003) · Antiviral Research · doi:10.1016/j.antiviral.2003.09.001 · Cited by 100
Oncolytic Activities of Host Defense Peptides
Al‐Benna, S., Shai, Y., Jacobsen, F., & Steinstraesser, L. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12118027 · Cited by 100
Endotoxin Neutralizing Peptides
Jerala, R., & Porro, M. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043388079 · Cited by 91
Yang, Q., Wang, C., Lang, L., Zhou, Y., Wang, H., & Shang, D. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0112-8 · Cited by 84
Antitumor and Angiostatic Activities of the Antimicrobial Peptide Dermaseptin B2
van Zoggel, H., Carpentier, G., Santos, C. D., Hamma‐Kourbali, Y., Courty, J., Amiche, M., & Delbé, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044351 · Cited by 83
Ueta, E., Tanida, T., & Osaki, T. (2001) · Journal of Peptide Research · doi:10.1111/j.1399-3011.2001.00821.x · Cited by 83
Kawamoto, M., Horibe, T., Kohno, M., & Kawakami, K. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-359 · Cited by 81
Wang, C., Tian, L., Li, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060462 · Cited by 79
Structure and function of a custom anticancer peptide, CB1a
Wu, J.-M., Jan, P.-S., Yu, H.-C., Haung, H.-Y., Fang, H., Chang, Y., Cheng, J.-W., & Chen, H. M. (2009) · Peptides · doi:10.1016/j.peptides.2009.02.004 · Cited by 79
Current trends in antimicrobial agent research: chemo- and bioinformatics approaches
Hammami, R., & Fliss, I. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.05.002 · Cited by 78
Design of Host Defence Peptides for Antimicrobial and Immunity Enhancing Activities
McPhee, J. B., Scott, M. G., & Hancock, R. E. W. (2005) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207053764558 · Cited by 76
McKeown, S., Lundy, F. T., Nelson, J., Lockhart, D., Irwin, C. R., Cowan, C. G., & Marley, J. J. (2006) · Oral Oncology · doi:10.1016/j.oraloncology.2005.11.005 · Cited by 76
Nishimura, M., Abiko, Y., Kurashige, Y., Takeshima, M., Yamazaki, M., Kusano, K., Saitoh, M., Nakashima, K., Inoue, T., & Kaku, T. (2004) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2004.07.001 · Cited by 75
Cancer vaccines: An update with special focus on ganglioside antigens (Review)
Bitton, R. J., Guthmann, M. D., Gabri, M. R., et al. (2002) · Oncology Reports · doi:10.3892/or.9.2.267 · Cited by 72
Wang, C., Zhou, Y., Li, S., Li, H., Tian, L., Wang, H., & Shang, D. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.03.016 · Cited by 70
Berge, G. M., Eliassen, L. T., Camilio, K. A., Bartnes, K., Sveinbjørnsson, B., & Rekdal, Ø. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0857-6 · Cited by 70
Koskimaki, J. E., Karagiannis, E. D., Roşca, E., Vesuna, F., Winnard, P. T., Raman, V., Bhujwalla, Z. M., & Popel, A. S. (2009) · Neoplasia · doi:10.1593/neo.09620 · Cited by 68
Janek, T., Krasowska, A., Radwańska, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057991 · Cited by 68
Intracellular delivery of bovine lactoferricin’s antimicrobial core (RRWQWR) kills T-leukemia cells
Richardson, A. M., de Antueno, R., Duncan, R., & Hoskin, D. W. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.083 · Cited by 65
Intratumoral Expression of Mature Human Neutrophil Peptide-1 Mediates Antitumor Immunity in Mice
Wang, Y., Li, D., Shi, H., Wen, Y., Yang, L., Xu, N., Chen, X., Chen, X., Chen, P., Li, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0484 · Cited by 65
Destouches, D., Huet, E., Sader, M., Fréchault, S., Carpentier, G., Ayoul, F., Briand, J., Ménashi, S., & Courty, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.380402 · Cited by 63
Fázio, M. A., Jouvensal, L., Vovelle, F., Bulet, P., de Miranda, M. T. M., Daffre, S., & Miranda, A. (2006) · Biopolymers · doi:10.1002/bip.20660 · Cited by 62
Fadnes, B., Rekdal, Ø., & Uhlin‐Hansen, L. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-183 · Cited by 61
Zhang, W., Li, J., Liu, L., Wang, K., Song, J., Yan, J., Li, Z.-Y., Zhang, B., & Wang, R. (2010) · Peptides · doi:10.1016/j.peptides.2010.06.019 · Cited by 60
Human neutrophil peptides 1, 2 and 3 are biochemical markers for metastatic colorectal cancer
Albrethsen, J., Møller, C. H., Olsen, J., Raskov, H., & Gammeltoft, S. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.05.039 · Cited by 59
Structural basis for the enhanced activity of cyclic antimicrobial peptides: The case of BPC194
Mika, J. T., Moiset, G., Cirac, A. D., Feliu, L., Bardajı́, E., Planas, M., Sengupta, D., Marrink, . J., & Poolman, B. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.05.001 · Cited by 59
Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives
Shang, B., Cao, Z., & Zhou, Q. (2012) · Frontiers of Medicine · doi:10.1007/s11684-012-0176-8 · Cited by 56
Lü, J., & Chen, Z. (2009) · Peptides · doi:10.1016/j.peptides.2009.09.028 · Cited by 52
Liu, S., Yang, H., Wan, L., Cheng, J., & Lu, X. (2013) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1328 · Cited by 49
Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells
Fadnes, B., Uhlin‐Hansen, L., Lindin, I., & Rekdal, Ø. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-116 · Cited by 46
Scanning electron microscopic analysis of breast aspirates
CHAUDHARY, J., & Munshi, M. M. (1995) · Cytopathology · doi:10.1111/j.1365-2303.1995.tb00469.x · Cited by 43
Ausbacher, D., Svineng, G., Hansen, T., & Strøm, M. B. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.07.005 · Cited by 40
Kozłowska, K., Nowak, J., Kwiatkowski, B., & Cichorek, M. (1999) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(99)80074-8 · Cited by 40
Antifungal and antitumor models of bioactive protective peptides
Rodrigues, E. G., Dobroff, A. S., Taborda, C. P., & Travassos, L. R. (2009) · Anais da Academia Brasileira de Ciências · doi:10.1590/s0001-37652009000300015 · Cited by 40
Interaction of Antimicrobial Peptide Magainin 2 with Gangliosides as a Target for Human Cell Binding
Miyazaki, Y., Aoki, M., Yano, Y., & Matsuzaki, K. (2012) · Biochemistry · doi:10.1021/bi301470h · Cited by 37
Jang, J. H., Kim, M. Y., Lee, J., Kim, S. C., & Cho, J. H. (2011) · Peptides · doi:10.1016/j.peptides.2011.02.010 · Cited by 37
Pelekanou, V., Kampa, M., Gallo, D., Notas, G., Troullinaki, M., Duvillier, H., Jacquot, Y., Stathopoulos, E. N., Castanas, E., & Leclercq, G. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.11.001 · Cited by 35
Edison, N., Reingewertz, T.-H., Gottfried, Y., Lev, T., Zuri, D., Maniv, I., Carp, M., Shalev, G., Friedler, A., & Larisch, S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1430 · Cited by 34
Jian-yin, M., Huang, F., Lin, H., & Wang, X. (2013) · Marine Drugs · doi:10.3390/md11010266 · Cited by 29
Kampa, M., Pelekanou, V., Gallo, D., Notas, G., Troullinaki, M., Pediaditakis, I., Charalampopoulos, I., Jacquot, Y., Leclercq, G., & Castanas, E. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23309 · Cited by 23
Lee, E., Roşca, E., Pandey, N. B., & Popel, A. S. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.08.020 · Cited by 23
A Peptide against Soluble Guanylyl Cyclase α1: A New Approach to Treating Prostate Cancer
Gao, S., Hsieh, C.-L., Bhansali, M., Kannan, A., & Shemshedini, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064189 · Cited by 18
Using functional genomics to overcome therapeutic resistance in hematological malignancies
Calderon, F. A., Gregory, M. A., & DeGregori, J. V. (2012) · Immunologic Research · doi:10.1007/s12026-012-8353-z · Cited by 18
Antitumor cell activity in vitro by myristoylated-peptide
Ourth, D. D. (2011) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2011.02.015 · Cited by 16
Cited by
The immunology of host defence peptides: beyond antimicrobial activity
Hancock, R. E. W., Haney, E. F., & Gill, E. E. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.29 · Cited by 945
Biomimetic peptide self-assembly for functional materials
Levin, A., Hakala, T. A., Schnaider, L., Bernardes, G. J. L., Gazit, E., & Knowles, T. P. J. (2020) · Nature Reviews Chemistry · doi:10.1038/s41570-020-0215-y · Cited by 853
Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design
Li, J., Koh, J.-J., Liu, S., Lakshminarayanan, R., Verma, C. S., & Beuerman, R. W. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00073 · Cited by 611
Human Antimicrobial Peptides and Proteins
Wang, G. (2014) · Pharmaceuticals · doi:10.3390/ph7050545 · Cited by 528
Evaluation of the use of therapeutic peptides for cancer treatment
Marqus, S., Pirogova, E., & Piva, T. J. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0328-x · Cited by 512
Metadata
- Authors
- Gaspar, D., Veiga, A. S., & Castanho, M. A. R. B.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 4
- Pages
- 294-294
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2153099927
- Cited by
- 749
- References
- 140
- FWCI
- 36.07
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.